VETERANS HEALTH ADMINISTRATION CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF COPD OR ASTHMA 
Collaborative Self-Management Education: SME Algorithm & Annotations (D3)

 A. Diagnostic Educational Process

    1. The patient should be oriented to the diagnostic procedures that have been ordered, and what the provider hopes to learn from them. It is important to impress upon the patient:
    1. Alert the patient to key aspects of a pulmonary function test: (e.g., reversibility, peak flows, the effect of inhaled medicines on changes in spirometry).

    2. Explain in simple language what the technologist will be doing:
    • "You will take a deep breath and blow into a tube. This breathing test measures how much and how fast air is exhaled."
    • "The measurements from the test are used to determine the type, severity, and the extent to which your lung disease can be reversed."
    1. Explain how testing will measure parameters before and after bronchodilators, and that the technologist may teach the initial use of an inhaler with and without a holding chamber.

    2. Tell the patient you will discuss the results during the return visit.
 
B. Has the Patient Completed the Diagnostic Process?¾ The technologist augmenting education in the lab (PFT or other) is expected to inform the clinician of the patient’s education in knowledge and skills, response and concerns by thorough comments in the medical record. This allows other team members to build on existing information, and not duplicate work. Educational components such as medication and inhaler use, use and monitoring peak flow meters or home oxygen evaluations, if performed as part of the diagnostic procedure, should be coordinated between the laboratory and other clinical settings (ED, acute inpatient care, and ambulatory care) to assure consistent instruction and reinforcement to the patient.

C. Discuss the Importance of a Diagnostic Workup¾ If a patient expresses hesitation in participating in workup, including diagnostic process, lab staff and clinicians should emphasize the importance of the test data in prescribing effective treatments.

D. Clinician/Patient Discuss Diagnosis, Prognosis, Treatment Plan Options
 
1. During this initial dialogue, focus on the patient’s concerns, quality of life, expectations and goals of the treatment (include target dates). Involve family or other caregiver in the discussion if desired by patient. Suggested questions to be asked include: Focus the discussion on what the patient needs to know (extraneous information will not be retained and will diminish the emphasis on important content).

2. Does the patient understand the relationship between symptoms (dyspnea, fatigue, sputum production, wheezing, and other symptoms) and the diagnosis?

3. Explain the disease process in categories of mild, moderate, severe, according to definitions in the medical algorithms. Most patients can understand loss of lung function as a percentage of normal. It is very important to help the patient/family understand the degree of reversibility and the need for reliever and slow controller medicines as well as the role of fast relievers.

4. Refer the patient/family to an asthma or COPD class whenever possible for thorough discussion of the disease process and interventions. If a referral is not possible, or to provide preliminary information, use educational materials that reinforce and supplement the discussion of disease processes, treatment plans and other necessary issues.

E. Implement or Refer for Education Specific to Medical Treatment
 

2. For ease of access, names are provided in the upper right hand corner for each intervention, healthy living, or prevention title; they are also referenced in the CONTENTS.
   
F. Implement or Refer for Education Specific to Healthy Living and Prevention¾ The format for SME specific to healthy living starts on page 23. It is designed the same as the SME for medical interventions.

G. Determine Understanding and Review Skills Taught in Initial Visit or from Referral

1. Patient understanding, performance and adherence to care plans should be assessed with each follow-up visit. The assessment may be performed by any properly trained member of the health care team. The essential information gained from the assessment is to be shared with the ordering provider to determine appropriate changes in the treatment plan.

2. To facilitate assessment, the patient should be encouraged to bring all portable and current medicines, delivery devices, peak flow meter, symptoms diaries and written treatment and action plans to all follow-up visits.

H. Does the Patient Understand the Care Plan ? 1. Adherence to a medicine and treatment plan is greater when the patient understands what to do, why, and when to do it. It should be expected that patient understanding of complex plans is evolutionary, dependent on repetitions and review of key program elements at each follow-up visit.

2. Elements of the treatment and action plans that are not understood should be reviewed. If the patient is unable to understand upon review, reassess the patient’s ability to understand. The provider should solicit information from the patient to determine the following:

I. Does the Patient Perform Skills Appropriately? 1. Demonstration/return demonstration is an essential component for teaching all medical interventions requiring psychomotor skills. For example, when inhalers are used, have the patient demonstrate self-administration with his or her own medicines, with and without holding chamber. If necessary, provide placebo and holding chamber for demonstration. Demonstration by the provider may help to gain the patient’s trust.

2. Can the patient perform key skills where psychomotor function is required? Recommended trigger/demonstration questions include:

J. Is the Patient Adhering to the Plan?   1. Having established that the patient understands and can perform skills in the care plan, the next key question is, "Are you doing it?" Understanding does not equate to adherence. Patients may be unwilling to admit they have not been following prescribed treatment. Determine which elements of the care plan, if any, are not being followed. Ask the patient why. Elements to reconsider when nonadherence is present: 2. Several activities and questions help to determine the level of patient adherence: K. Is the Management Plan Consistent with Current Goals? 1. As the management plan changes, the education, to impart the essential knowledge and skills to support any new interventions, must also be added. Assessments of the new interventions are expected with every follow-up visit.

2. The patient’s behavior, comprehension and retention can change over time. Adherence to care plans improves with regular periodic review of all elements, with key elements reviewed at each follow-up session.

L. Identify whether this is a Patient or System Problem 1. System problems¾ unable to get medicines, not given a care plan, poor access. 2. Patient problems¾ inconvenient treatment regime, doesn’t like taste of medicine, medicine side effects, can’t read plan, forgets to take medicines, denial, and frustration with care system.
Module D2 | Table of Contents | Module D4